Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|October 18, 2022
Evaluation of Antitumor and On-Target Activity of HDAC Inhibitors with the Zebrafish Embryo Xenograft ModelCharlotte Gatzweiler, Johannes Ridinger, Simay Ayhan, et al.Pharmaceuticals (Basel, Switzerland)|October 30, 2020
Rapid In Vivo Validation of HDAC Inhibitor-Based Treatments in Neuroblastoma Zebrafish XenograftsJagoda K Wrobel, Sara Najafi, Simay Ayhan, et al.Cancers|September 10, 2021
Combining APR-246 and HDAC-Inhibitors: A Novel Targeted Treatment Option for NeuroblastomaMichael Müller, Lisa Rösch, Sara Najafi, et al.Cancers|February 15, 2022
Functional Therapeutic Target Validation Using Pediatric Zebrafish Xenograft ModelsCharlotte Gatzweiler, Johannes Ridinger, Sonja Herter, et al.Journal of Neuro-Oncology|May 14, 2023
Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cellsGintvile Valinciute, Jonas Ecker, Florian Selt, et al.Neuro-Oncology|July 26, 2022
The first-in-class ERK inhibitor ulixertinib shows promising activity in mitogen-activated protein kinase (MAPK)-driven pediatric low-grade glioma modelsRomain Sigaud, Lisa Rösch, Charlotte Gatzweiler, et al.Pageof 1